Nevin Fazlıoglu

Mrs. Nevin Fazlıoglu

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2021 in Sleep and Breathing
Verified
Journal Article
Closed access
PDF file
TETolga Ersözlü
Tolga Ersözlü
MDMahmut Deniz
Mahmut Deniz
NFNevin Fazlıoglu
Nevin Fazlıoglu
EGErdogan Gultekin
Erdogan Gultekin
NANejat Altintas
Nejat Altintas

24 September 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
NFNevin Fazlıoglu
Nevin Fazlıoglu
PUPelin Uysal
Pelin Uysal
SDSinem Durmus
Sinem Durmus
SYSibel Yurt
Sibel Yurt
RGRemise Gelisgen
Remise Gelisgen
HUHafize Uzun
Hafize Uzun
Objective: Obstructive sleep apnea syndrome (OSAS) is a common sleep disorder that is caused by the reduction or cessation of airflow in the upper airway. Irisin, retinol-binding protein-4 (RBP-4), and adiponectin are the three significant factors in the metabolic process of the human body. The objective of this study was to investigate whether plasma irisin, RBP-4, and adiponectin levels are associated with the severity of OSAS. Methods: According to inclusion and exclusion criteria, 125 patients with OSAS and 46 healthy, gender-matched controls were included in this study. The patients were classified according to the apnea hypopnea index (AHI) as 14 mild cases (5 < AHI < 15), 23 moderate OSAS cases (15 < AHI < 30), and 88 severe OSAS cases (AHI > 30). The plasma irisin, RBP-4, and adiponectin levels were measured and compared between groups. Results: RBP-4 levels were higher in severe OSAS compared to other groups, and irisin levels were significantly lower in severe OSAS compared to other groups. There was a negative correlation between irisin and RBP-4 (r = −0.421; p < 0.001), and irisin and AHI (r = −0.834; p < 0.001), and a positive correlation between irisin and adiponectin (r = 0.240; p = 0.002). There was a negative correlation between RBP-4 and adiponectin (r = −0.507; p < 0.001) and a positive correlation between RBP-4 and AHI (r = 0.473; p < 0.001). As a predictor of OSAS, adiponectin showed the highest specificity (84.8%) and RBP-4 the highest sensitivity (92.0%). Conclusion: Circulating adiponectin, irisin, and RBP-4 may be new biomarkers in OSAS patients in addition to risk factors such as diabetes, obesity, and hypertension. When polysomnography is not available, these parameters and clinical data can be used to diagnose the disease. As a result, patients with an AHI score greater than thirty should be closely monitored for metabolic abnormalities.

5 March 2025 in Respiratory Medicine
Verified
Journal Article
Closed access
SESibel Emre
Sibel Emre
NFNevin Fazlıoglu
Nevin Fazlıoglu
EEErsan Emre
Ersan Emre
LMLevent Cem Mutlu
Levent Cem Mutlu
AYAhsen Yılmaz
Ahsen Yılmaz

1 June 2025 in Nature and Science of Sleep
Verified
Journal Article
Open access
PDF file
NFNevin Fazlıoglu
Nevin Fazlıoglu
CACihan Aydın
Cihan Aydın
ADAykut Demirkıran
Aykut Demirkıran
DGDemet Özkaramanlı Gür
Demet Özkaramanlı Gür
AYAhsen Yılmaz
Ahsen Yılmaz
ACAliye Celikkol
Aliye Celikkol
Objective: Obstructive sleep apnea syndrome (OSAS) increases the risk of vascular dysfunction by causing hypoxemia due to recurrent obstructions in the upper airway. This can put pressure on the vasculature and impair endothelial function. SCUBE-1 gains importance in OSAS as a biomarker that may reflect this dysfunction. We focused in this study on the association between levels of SCUBE-1 and endothelial dysfunction in patients suffering from OSAS. Methods: A study population of 75 individuals participated in the study. Participants were categorized as normal (n=18), mild OSAS (n=22), moderate OSAS (n=19) and severe OSAS (n=16) according to polysomnography findings. Evaluation parameters included SCUBE-1 levels, polysomnography measurements, flow-mediated dilatation (FMD), carotid intima-media thickness (CIMT), and comprehensive laboratory analyses. Results: SCUBE-1 levels were significantly higher in the severe OSAS group (15.8 ± 4.2 ng/mL, p< 0.001). SCUBE-1 showed a moderate negative correlation with FMD (r = − 0.248, p < 0.001) and a significant negative correlation with CIMT (r = − 0.512, p < 0.001). ROC analysis demonstrated good diagnostic accuracy (AUC: 0.871, 95% CI: 0.797– 0.945) for SCUBE-1 in identifying severe OSAS. Conclusion: OSAS severity correlates with the rise in SCUBE-1 levels, and this biomarker may serve as an important attribute in profiling endothelial dysfunction. SCUBE-1 can indeed be an effective biomarker to identify subtle changes in the vascular biology of OSAS patients and aid early interventions.

16 August 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
NFNevin Fazlıoglu
Nevin Fazlıoglu
PUPelin Uysal
Pelin Uysal
SDSinem Durmus
Sinem Durmus
SYSi̇bel Yurt
Si̇bel Yurt
RGRemise Gelisgen
Remise Gelisgen
HUHafize Uzun
Hafize Uzun
Objective: Obstructive sleep apnea syndrome (OSAS) is a common sleep disorder that is caused by the reduction or cessation of airflow in the upper airway. Irisin, retinol-binding protein-4 (RBP-4), and adiponectin are the three significant factors in the metabolic process of the human body. The objective of this study was to investigate whether plasma irisin, RBP-4, and adiponectin levels are associated with the severity of OSAS. Methods: According to inclusion and exclusion criteria, 125 patients with OSAS and 46 healthy, gender matched controls were included to the study. The patients were classified according to the apnea hypopnea index (AHI) as 14 mild cases (5<AHI<15), 23 moderate OSAS cases (15<AHI30). The plasma irisin, RBP-4 and adiponectin levels were measured and compared between groups. Results: RBP-4 levels were higher in severe OSAS compared to moderate (p<0.05) and mild (p<0.001) OSAS groups, irisin levels were significantly lower compared to moderate (p<0.05) and mild (p<0.001) OSAS groups. There was a negative correlation between irisin and RBP-4 (r=-0.379; p<0.001) and AHI (r=-0.834; p<0.001) and a positive correlation with minimum oxygen saturation (MOS) (r=0.341; p<0.001) in the patient group. In the patient group, there was a negative correlation between adiponectin and BMI (r=-0.682; p<0.001), RBP-4 (r=-0.292; p<0.01) and AHI (r=-0.179; p<0.05) and a positive correlation with MOS (r=0.397; p<0.001). In the patient group, there was a positive correlation between RBP-4 and BMI (r=0.406; p<0.001) and AHI (r=0.473; p<0.001) and a negative correlation with MOS (r=-0.805; p<0.001). As a predictor of OSAS, adiponectin showed the highest specificity (84.8%) and RBP-4 the highest sensitivity (92.0%). Conclusion: The results of the present study demonstrated that the severity of OSAS causes more metabolic problems, including decreased plasma irisin and adiponectin levels and an increased plasma RBP-4 level. As a result, patients with an AHI score greater than thirty should be closely monitored for metabolic and cardiovascular abnormalities.

15 September 2020 in Tuberk Toraks
Verified
Journal Article
Closed access
MKMehtap Pehlivanlar Küçük
Mehtap Pehlivanlar Küçük
TÖTevfik Özlü
Tevfik Özlü
AKAhmet Oğuzhan Küçük
Ahmet Oğuzhan Küçük
AKAkın Kaya
Akın Kaya
CKCenk Kıraklı
Cenk Kıraklı
ZDZerrin Gürel Durmuş
Zerrin Gürel Durmuş
Introduction: Intensive care physicians are increasingly involved in decision making about the prognosis of intensive care unit ICU patients. With this study; we aimed to evaluate the power of clinician foresight at prediction of mortality in patient at triage to intensive care and patient follow-up. Materials and Methods: This study was conducted in ICUs located in various geographical regions of Turkey between January 1, 2017-April 30, 2017. The clinical research was planned as observational, multicenter, cross-sectional. Results: A total of 1169 intubated patients were followed in 37 different ICU. At the beginning of the follow-up we asked the physician who will follow the patient in the ICU to give a score for the probability of survival of the patients. Scoring included a total of 6 scores from 0 to 5, with the "0" the worst probability "5" being the best. According to this distribution, only 1 (0.9%) of 113 patients who were given 0 points survived. Three (6.1%) of 49 with the best score of 5 died. Survival rates were significantly different in each score group (r: -0.488; p< 0.001). After the combined mortality estimation scores based on the clinical observations of the physicians (0 and 1 point score was combined as non-survive, 4 and 5 score was combined as survived) 320 of the 545 patients were estimated to be dead and 225 were predicted survival. Sensitivity and spesifity of scoring system to predict mortality was 91.56% (95% Cl: 87.96-94.37), 76.89% (95% CI: 70.82-82.23) respectively. Conclusion: In this study, we concluded that the physicians who follow the patients in the ICU can predict the poor prognosis at the time of admission and the high mortality rate. The physician's opinion on mortality estimation should be considered in intensive care mortality scoring in addition to other laboratory and clinical parameters.